| Year |
Citation |
Score |
| 2016 |
Richfield E, Prasad K, Brenneman M, Goraczniak R, Gunderson S. 259. Targeted Gene Silencing by U1 Adaptor Oligonucleotides in Preclinical Models of Parkinson's Disease and Huntington's Disease Molecular Therapy. 24: S102. DOI: 10.1016/S1525-0016(16)33068-4 |
0.331 |
|
| 2013 |
Ramos RL, Van Dine SE, George E, Patel D, Hoplight BJ, Leheste JR, Richfield EK, Torres G. Molecular layer heterotopia of the cerebellar vermis in mutant and transgenic mouse models on a C57BL/6 background. Brain Research Bulletin. 97: 63-8. PMID 23735805 DOI: 10.1016/J.Brainresbull.2013.05.001 |
0.329 |
|
| 2013 |
Mangaru Z, Salem E, Sherman M, Van Dine SE, Bhambri A, Brumberg JC, Richfield EK, Gabel LA, Ramos RL. Neuronal migration defect of the developing cerebellar vermis in substrains of C57BL/6 mice: cytoarchitecture and prevalence of molecular layer heterotopia. Developmental Neuroscience. 35: 28-39. PMID 23428637 DOI: 10.1159/000346368 |
0.33 |
|
| 2011 |
Yin L, Lu L, Prasad K, Richfield EK, Unger EL, Xu J, Jones BC. Genetic-based, differential susceptibility to paraquat neurotoxicity in mice. Neurotoxicology and Teratology. 33: 415-21. PMID 21371552 DOI: 10.1016/J.Ntt.2011.02.012 |
0.389 |
|
| 2011 |
Prasad K, Tarasewicz E, Strickland PA, O'Neill M, Mitchell SN, Merchant K, Tep S, Hilton K, Datwani A, Buttini M, Mueller-Steiner S, Richfield EK. Biochemical and morphological consequences of human α-synuclein expression in a mouse α-synuclein null background. The European Journal of Neuroscience. 33: 642-56. PMID 21272100 DOI: 10.1111/J.1460-9568.2010.07558.X |
0.384 |
|
| 2010 |
Prasad K, Richfield EK. Number and nuclear morphology of TH+ and TH- neurons in the mouse ventral midbrain using epifluorescence stereology. Experimental Neurology. 225: 328-40. PMID 20637754 DOI: 10.1016/J.Expneurol.2010.07.004 |
0.318 |
|
| 2009 |
Prasad K, Tarasewicz E, Mathew J, Strickland PA, Buckley B, Richardson JR, Richfield EK. Toxicokinetics and toxicodynamics of paraquat accumulation in mouse brain. Experimental Neurology. 215: 358-67. PMID 19084006 DOI: 10.1016/J.Expneurol.2008.11.003 |
0.317 |
|
| 2008 |
Prasad K, Richfield EK. Sporadic midbrain dopamine neuron abnormalities in laboratory mice. Neurobiology of Disease. 32: 262-72. PMID 18687402 DOI: 10.1016/J.Nbd.2008.07.007 |
0.375 |
|
| 2007 |
Prasad K, Winnik B, Thiruchelvam MJ, Buckley B, Mirochnitchenko O, Richfield EK. Prolonged toxicokinetics and toxicodynamics of paraquat in mouse brain. Environmental Health Perspectives. 115: 1448-53. PMID 17938734 DOI: 10.1289/Ehp.9932 |
0.325 |
|
| 2007 |
Barlow BK, Cory-Slechta DA, Richfield EK, Thiruchelvam M. The gestational environment and Parkinson's disease: evidence for neurodevelopmental origins of a neurodegenerative disorder. Reproductive Toxicology (Elmsford, N.Y.). 23: 457-70. PMID 17350799 DOI: 10.1016/J.Reprotox.2007.01.007 |
0.371 |
|
| 2006 |
Chen L, Thiruchelvam MJ, Madura K, Richfield EK. Proteasome dysfunction in aged human alpha-synuclein transgenic mice. Neurobiology of Disease. 23: 120-6. PMID 16713278 DOI: 10.1016/J.Nbd.2006.02.004 |
0.342 |
|
| 2005 |
Cory-Slechta DA, Thiruchelvam M, Barlow BK, Richfield EK. Developmental pesticide models of the Parkinson disease phenotype. Environmental Health Perspectives. 113: 1263-70. PMID 16140639 DOI: 10.1289/Ehp.7570 |
0.417 |
|
| 2005 |
Thiruchelvam M, Prokopenko O, Cory-Slechta DA, Richfield EK, Buckley B, Mirochnitchenko O. Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype. The Journal of Biological Chemistry. 280: 22530-9. PMID 15824117 DOI: 10.1074/Jbc.M500417200 |
0.363 |
|
| 2005 |
Cory-Slechta DA, Thiruchelvam M, Richfield EK, Barlow BK, Brooks AI. Developmental pesticide exposures and the Parkinson's disease phenotype. Birth Defects Research. Part a, Clinical and Molecular Teratology. 73: 136-9. PMID 15751039 DOI: 10.1002/Bdra.20118 |
0.412 |
|
| 2004 |
Barlow BK, Richfield EK, Cory-Slechta DA, Thiruchelvam M. A fetal risk factor for Parkinson's disease. Developmental Neuroscience. 26: 11-23. PMID 15509894 DOI: 10.1159/000080707 |
0.379 |
|
| 2004 |
Reeves R, Thiruchelvam M, Richfield EK, Cory-Slechta DA. The effect of developmental exposure to the fungicide triadimefon on behavioral sensitization to triadimefon during adulthood. Toxicology and Applied Pharmacology. 200: 54-63. PMID 15451308 DOI: 10.1016/J.Taap.2004.03.020 |
0.395 |
|
| 2004 |
Thiruchelvam MJ, Powers JM, Cory-Slechta DA, Richfield EK. Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice. The European Journal of Neuroscience. 19: 845-54. PMID 15009131 DOI: 10.1111/J.0953-816X.2004.03139.X |
0.339 |
|
| 2003 |
Reeves R, Thiruchelvam M, Richfield EK, Cory-Slechta DA. Behavioral sensitization and long-term neurochemical alterations associated with the fungicide triadimefon. Pharmacology, Biochemistry, and Behavior. 76: 315-26. PMID 14592684 DOI: 10.1016/J.Pbb.2003.08.003 |
0.405 |
|
| 2003 |
Thiruchelvam M, McCormack A, Richfield EK, Baggs RB, Tank AW, Di Monte DA, Cory-Slechta DA. Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. The European Journal of Neuroscience. 18: 589-600. PMID 12911755 DOI: 10.1046/J.1460-9568.2003.02781.X |
0.388 |
|
| 2003 |
Barlow BK, Thiruchelvam MJ, Bennice L, Cory-Slechta DA, Ballatori N, Richfield EK. Increased synaptosomal dopamine content and brain concentration of paraquat produced by selective dithiocarbamates. Journal of Neurochemistry. 85: 1075-86. PMID 12716439 DOI: 10.1046/J.1471-4159.2003.01773.X |
0.395 |
|
| 2002 |
Thiruchelvam M, Richfield EK, Goodman BM, Baggs RB, Cory-Slechta DA. Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology. 23: 621-33. PMID 12428734 DOI: 10.1016/S0161-813X(02)00092-X |
0.379 |
|
| 2002 |
Richfield EK, Thiruchelvam MJ, Cory-Slechta DA, Wuertzer C, Gainetdinov RR, Caron MG, Di Monte DA, Federoff HJ. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Experimental Neurology. 175: 35-48. PMID 12009758 DOI: 10.1006/Exnr.2002.7882 |
0.374 |
|
| 2002 |
Richfield EK, Vonsattel JP, MacDonald ME, Sun Z, Deng YP, Reiner A. Selective loss of striatal preprotachykinin neurons in a phenocopy of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 327-32. PMID 11921119 DOI: 10.1002/Mds.10032 |
0.354 |
|
| 2000 |
Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, Cory-Slechta DA. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 9207-14. PMID 11124998 DOI: 10.1523/Jneurosci.20-24-09207.2000 |
0.419 |
|
| 2000 |
Thiruchelvam M, Brockel BJ, Richfield EK, Baggs RB, Cory-Slechta DA. Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease? Brain Research. 873: 225-34. PMID 10930548 DOI: 10.1016/S0006-8993(00)02496-3 |
0.389 |
|
| 1998 |
McCoy L, Cox C, Richfield EK. Antipsychotic drug regulation of AMPA receptor affinity states and GluR1, GluR2 splice variant expression. Synapse (New York, N.Y.). 28: 195-207. PMID 9488504 DOI: 10.1002/(Sici)1098-2396(199803)28:3<195::Aid-Syn2>3.0.Co;2-5 |
0.352 |
|
| 1997 |
McCoy L, Richfield EK, Cory-Slechta DA. Regional decreases in alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid ([3H]AMPA) and 6-[3H]cyano-7-nitroquinoxaline-2,3-dione ([3H]CNQX) binding in response to chronic low-level lead exposure: reversal versus potentiation by chronic dopamine agonist treatment. Journal of Neurochemistry. 69: 2466-76. PMID 9375679 DOI: 10.1046/J.1471-4159.1997.69062466.X |
0.405 |
|
| 1997 |
Cory-Slechta DA, McCoy L, Richfield EK. Time course and regional basis of Pb-induced changes in MK-801 binding: reversal by chronic treatment with the dopamine agonist apomorphine but not the D1 agonist SKF-82958. Journal of Neurochemistry. 68: 2012-23. PMID 9109527 DOI: 10.1046/J.1471-4159.1997.68052012.X |
0.412 |
|
| 1996 |
McCoy L, Cox C, Richfield EK. Chronic treatment with typical and atypical antipsychotics increases the AMPA-preferring form of AMPA receptor in rat brain. European Journal of Pharmacology. 318: 41-5. PMID 9007511 DOI: 10.1016/S0014-2999(96)00910-7 |
0.313 |
|
| 1996 |
Voorn P, Brady LS, Berendse HW, Richfield EK. Densitometrical analysis of opioid receptor ligand binding in the human striatum--I. Distribution of mu opioid receptor defines shell and core of the ventral striatum. Neuroscience. 75: 777-92. PMID 8951872 DOI: 10.1016/0306-4522(96)00271-0 |
0.365 |
|
| 1996 |
Vonkeman HE, Voorn P, Brady LS, Berendse HW, Richfield EK. Opioid receptor ligand binding in the human striatum: II. Heterogeneous distribution of kappa opioid receptor labeled with [3H]bremazocine. The Journal of Comparative Neurology. 374: 223-9. PMID 8906495 DOI: 10.1002/(Sici)1096-9861(19961014)374:2<223::Aid-Cne5>3.0.Co;2-4 |
0.367 |
|
| 1996 |
Pokora MJ, Richfield EK, Cory-Slechta DA. Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments. Journal of Neurochemistry. 67: 1540-50. PMID 8858938 DOI: 10.1046/J.1471-4159.1996.67041540.X |
0.412 |
|
| 1996 |
McCoy L, Richfield EK. Chronic antipsychotic treatment alters glycine-stimulated NMDA receptor binding in rat brain. Neuroscience Letters. 213: 137-41. PMID 8858627 DOI: 10.1016/0304-3940(96)12834-2 |
0.334 |
|
| 1995 |
Richfield EK, Maguire-Zeiss KA, Vonkeman HE, Voorn P. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients. Annals of Neurology. 38: 852-61. PMID 8526457 DOI: 10.1002/Ana.410380605 |
0.331 |
|
| 1995 |
Richfield EK, Maguire-Zeiss KA, Cox C, Gilmore J, Voorn P. Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients. Annals of Neurology. 37: 335-43. PMID 7695232 DOI: 10.1002/Ana.410370309 |
0.339 |
|
| 1995 |
Thomas LB, Gates DJ, Richfield EK, O'Brien TF, Schweitzer JB, Steindler DA. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Experimental Neurology. 133: 265-72. PMID 7649231 DOI: 10.1006/Exnr.1995.1029 |
0.303 |
|
| 1995 |
Richfield EK, Maguire-Zeiss KA, Vonkemann HE, Voorn P. Preferential Loss Of Preproenkephalin Versus Preprotachykinin Striatal Neurons From HuntingtonʼS Disease Patients: 190 Journal of Neuropathology and Experimental Neurology. 54: 458. DOI: 10.1097/00005072-199505000-00206 |
0.319 |
|
| 1994 |
Veenman CL, Albin RL, Richfield EK, Reiner A. Distributions of GABAA, GABAB, and benzodiazepine receptors in the forebrain and midbrain of pigeons. The Journal of Comparative Neurology. 344: 161-89. PMID 8077457 DOI: 10.1002/Cne.903440202 |
0.326 |
|
| 1994 |
Richfield EK, Herkenham M. Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Annals of Neurology. 36: 577-84. PMID 7944290 DOI: 10.1002/Ana.410360406 |
0.403 |
|
| 1994 |
Voorn P, Brady LS, Schotte A, Berendse HW, Richfield EK. Evidence for two neurochemical divisions in the human nucleus accumbens. The European Journal of Neuroscience. 6: 1913-6. PMID 7704301 DOI: 10.1111/J.1460-9568.1994.Tb00582.X |
0.384 |
|
| 1993 |
Berendse HW, Richfield EK. Heterogeneous distribution of dopamine D1 and D2 receptors in the human ventral striatum. Neuroscience Letters. 150: 75-9. PMID 8097026 DOI: 10.1016/0304-3940(93)90112-X |
0.357 |
|
| 1992 |
Inglefield JR, Richfield EK. Preservation of the density of the dopamine uptake complex in aging Fischer 344 rat brain. Neurobiology of Aging. 13: 383-91. PMID 1625767 DOI: 10.1016/0197-4580(92)90112-B |
0.343 |
|
| 1992 |
Van Dort ME, Kilbourn MR, Chakraborty PK, Richfield EK, Gildersleeve DL, Wieland DM. Iodine-125 and fluorine-18 labeled aryl-1,4-dialkylpiperazines: potential radiopharmaceuticals for in vivo study of the dopamine uptake system. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 43: 671-80. PMID 1325425 DOI: 10.1016/0883-2889(92)90039-H |
0.35 |
|
| 1991 |
Herkenham M, Groen BG, Lynn AB, De Costa BR, Richfield EK. Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum. Brain Research. 552: 301-10. PMID 1913192 DOI: 10.1016/0006-8993(91)90096-E |
0.355 |
|
| 1991 |
Herkenham M, Lynn AB, de Costa BR, Richfield EK. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Research. 547: 267-74. PMID 1909204 DOI: 10.1016/0006-8993(91)90970-7 |
0.435 |
|
| 1991 |
Richfield EK, O'Brien CF, Eskin T, Shoulson I. Heterogeneous dopamine receptor changes in early and late Huntington's disease. Neuroscience Letters. 132: 121-6. PMID 1838580 DOI: 10.1016/0304-3940(91)90448-3 |
0.381 |
|
| 1991 |
Richfield EK. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics. Brain Research. 540: 1-13. PMID 1829013 DOI: 10.1016/0006-8993(91)90486-F |
0.373 |
|
| 1989 |
Richfield EK, Penney JB, Young AB. Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system. Neuroscience. 30: 767-77. PMID 2528080 DOI: 10.1016/0306-4522(89)90168-1 |
0.356 |
|
| 1989 |
Richfield EK, Young AB, Penney JB. Comparative distributions of dopamine D-1 and D-2 receptors in the cerebral cortex of rats, cats, and monkeys. The Journal of Comparative Neurology. 286: 409-26. PMID 2506254 DOI: 10.1002/Cne.902860402 |
0.336 |
|
| 1987 |
Richfield EK, Young AB, Penney JB. Comparative distribution of dopamine D-1 and D-2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys. The Journal of Comparative Neurology. 262: 446-63. PMID 2958517 DOI: 10.1002/Cne.902620308 |
0.38 |
|
| 1987 |
Richfield EK, Debowey DL, Penney JB, Young AB. Basal ganglia and cerebral cortical distribution of dopamine D1- and D2-receptors in neonatal and adult cat brain. Neuroscience Letters. 73: 203-8. PMID 2951618 DOI: 10.1016/0304-3940(87)90245-X |
0.357 |
|
| 1986 |
Richfield EK, Young AB, Penney JB. Properties of D2 dopamine receptor autoradiography: high percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections. Brain Research. 383: 121-8. PMID 3768686 DOI: 10.1016/0006-8993(86)90013-2 |
0.394 |
|
| 1984 |
Jastrow TRd, Richfield EK, Gnegy ME. Quantitative autoradiography of [3H]sulpiride binding sites in rat brain. Neuroscience Letters. 51: 47-53. PMID 6083509 DOI: 10.1016/0304-3940(84)90261-1 |
0.326 |
|
| Show low-probability matches. |